KING OF
PRUSSIA, Pa., Oct. 28,
2024 /PRNewswire/ -- RBQM innovator CluePoints has
today announced that Richard Young
has been appointed as its new Chief Strategy Officer. With 30 years
of experience in clinical data management, Richard is an expert in
his field.
Richard has previous experience at Medidata, Cmed Group and
PAREXEL International. His most recent role was Vice President,
Strategy, Clinical Data, at Veeva Systems. Richard has also acted
as the Conference Committee Leader for the SCDM Annual Conference
for the past three years, and is currently leading their
innovations committee. His wealth of experience will ensure
CluePoints' continued growth and development as the leading
provider of integrated data review software.
Andy Cooper, CEO at
CluePoints, commented: "At CluePoints we are committed to
innovation and turning data into positive outcomes in clinical
trials. Richard has extensive experience of clinical data
management and data review, and is a well-regarded expert in his
field. His thought leadership is exemplified through his successful
podcast series and work on industry forums. Richard sees the
journey we are on, our mission to provide the best-in-class
integrated data interrogation and risk management platform, and
wants to support us on that continued journey."
Richard Young reinforced
the opportunities on offer: "Our industry is living through a
digital inflection point, with technology offering us the
opportunity to fuel and deliver step changes into global
healthcare. Having successfully delivered Veeva Clinical Data, I
want to contribute to the next step in realizing the potential for
data to reshape and redefine research and development. I believe
CluePoints is the perfect place to do that."
Andy Cooper, CEO at
CluePoints, added: "Richard will drive the strategy for our
product portfolio ensuring the value of our products is aligned
with our customers' needs and we are planning, not just for what is
needed this year, but what is needed in five years' time. He will
ensure we remain a leader in RBQM while also establishing ourselves
as the market leader for integrated AI-driven SaaS solutions to
analyze and interrogate clinical trial data."
To learn more about CluePoints' award-winning solutions, please
visit www.cluepoints.com
About CluePoints
CluePoints is the premier Risk-Based Quality
Management (RBQM) and Data Quality Oversight Software
provider. We are leveraging the potential of Artificial
Intelligence using Advanced Statistics and Machine Learning to
determine the quality, accuracy, and integrity of clinical
trial data both during and after study conduct. Aligned with
guidance from the FDA, EMA, and ICH E6 (R2), CluePoints is
deployed to support central and on-site monitoring, medical
review, quality risk management and to drive a holistic
Risk-Based strategy in all trials. Coupled with thought
leadership and consulting expertise to aid pre-study risk
assessment, identification of risk controls and
solution implementation, you now have everything you need to
adhere with global regulatory guidance. The result is positive
clinical development outcomes, increased operational
efficiency, lower costs and reduced regulatory submission risk
as part of the industry paradigm shift to RBQM.
View original
content:https://www.prnewswire.co.uk/news-releases/cluepoints-appoints-richard-young-as-chief-strategy-officer-302288017.html